Neuroscience and Behavioral Physiology

, Volume 38, Issue 9, pp 913–916 | Cite as

Intracerebral development of transplanted glioblastoma C6 cells in rats after preliminary exposure to neuropeptides and an MAPK inhibitor

  • Ts. S. Tencheva
  • I. R. Panov


The invasive growth, proliferation, and transcriptional regulation of glioma C6 cells treated with endothelin-1 and PD98059, a specific inhibitor of ERK1/2 were studied. The proliferation of glioma C6 cells was assessed in different growth conditions by prior in vitro treatment with endothelin-1 followed by implantation into the brain. In vitro studies showed that PD98059 inhibited the proliferation of cultured glioma C6 cells and activated transcription factors E2F1 and Myc-Max. Endothelin-1 significantly increased the proliferation of glioma C6 cells. The model used in this study was experimental and may allow the specific features of the in vitro behavior of cultured invasive cells to be identified.

Key Words

glioma cells proliferation transplantation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    N. C. Andrews and D. V. Fuller, “A rapid micropreparation technique for extraction of DNA-binding proteins from limiting number of mammalian cells,” Nucl. Acids Res., 19, 24 (1991).CrossRefGoogle Scholar
  2. 2.
    J. Barg, M. M. Belcheva, R. Levy, et al., “Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells,” J. Neurosci., 14, 5858–5864 (1994).PubMedGoogle Scholar
  3. 3.
    K. Blumer and G. Johnson, “Diversity in function and regulation of MAP kinase pathways,” Trends Biochem. Sci., 19, 236–240 (1994).PubMedCrossRefGoogle Scholar
  4. 4.
    E. Cane and L. Mahadevan, “Parallel signaling processing among mammalian MAPKS,” Trends Biochem. Sci., 20, 117–122 (1995).CrossRefGoogle Scholar
  5. 5.
    L. Chang and M. Karin, “Mammalian MAP kinase signaling cascades,” Nature, 410, 37–40 (2001).PubMedCrossRefGoogle Scholar
  6. 6.
    P.-O. Courand, O. Durieu-Trautmann, D. L. Nguyen, et al., “Functional endothelin-1 receptors in rat astrocytoma C6,” Eur. J. Pharmacol., 206, 191–198 (1991).CrossRefGoogle Scholar
  7. 7.
    N. Dyson, “The regulation of E2F by pRB-family proteins,” Genes Dev., 12, 2245–2262 (1998).PubMedCrossRefGoogle Scholar
  8. 8.
    J. R. Nevins, “Toward an understanding of the functional complexity of the E2F and retinoblastoma families,” Cell Growth Differ., 9, 585–593 (1998).PubMedGoogle Scholar
  9. 9.
    J. R. Nevins, “The Rb/E2F pathway and cancer,” Hum. Mol. Genet., 10, 699–703 (2001).PubMedCrossRefGoogle Scholar
  10. 10.
    A. Saito, R. Shiba, S. Kimura, et al., “Vasoconstrictor responses of large cerebral arteries of cats to endothelin, an endothelium-derived vasoactive peptide,” Eur. J. Pharmacol., 162, 353–358 (1989).PubMedCrossRefGoogle Scholar
  11. 11.
    P. J. S. Stork and J. M. Schmitt, “Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation,” Trends Cell Biol., 12, 258–266 (2002).PubMedCrossRefGoogle Scholar
  12. 12.
    Z. S. Tencheva, M. M. Belcheva, A. A. Velichkova, et al., “Opioid regulation of AP-1 DNA binding activity in NG 108-15 cells under conditions of opioid receptor adaptation,” Mol. Brain Res., 48, 156–158 (1997).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • Ts. S. Tencheva
    • 1
  • I. R. Panov
    • 2
  1. 1.Institute of PhysiologyBulgarian Academy of SciencesSofiaBulgaria
  2. 2.Lozenets University HospitalSofiaBulgaria

Personalised recommendations